A futility study of minocycline in Huntington's disease.
about
Bridge between neuroimmunity and traumatic brain injuryMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Minocycline protection of neomycin induced hearing loss in gerbils.Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor.Therapeutic advances in Huntington's Disease.Minocycline- and tetracycline-class antibiotics are protective against partial seizures in vivo.The futility study--Progress over the last decade.Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progressionBiotic acts of antibioticsHigh-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trialLaquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells.Designing clinical trials for dystonia.Milestones in movement disorders clinical trials: advances and landmark studies.The executioners sing a new song: killer caspases activate microglia.Nanoparticles in the brain: a potential therapeutic system targeted to an early defect observed in many neurodegenerative diseases.Neuroprotective effects of psychotropic drugs in Huntington's diseaseThe most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials.Animal models of Huntington's disease for translation to the clinic: best practices.Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.Analysis of Participant Withdrawal in Huntington Disease Clinical Trials.Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.Huntington's Disease-Update on Treatments.Minocycline reduces spontaneous hemorrhage in mouse models of cerebral amyloid angiopathy.Promises and pitfalls of immune-based strategies for Huntington's disease.Revisiting the neuropsychiatry of Huntington's disease.Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialRating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations
P2860
Q26827612-F9CC33AC-A322-4854-9A95-C074B93FD379Q27005950-C905E8A0-49DD-4D42-AE2D-5A7B313CEB69Q30412597-B24B7F2E-672F-44C8-BC8E-9D79395E523EQ31104505-9794BF4D-C098-4FE1-B8E4-25A2EBD8DC4FQ34487604-D5B955E2-39B9-42A7-8409-66A667D0F25EQ34638224-FE580686-6812-459D-99C0-92A4816E5A78Q36264697-A5FDDC34-896B-40DA-81AB-15402EBE22AEQ37071340-022B2BFA-8787-4277-8C14-0266BFAE5774Q37101851-88699FC8-2954-46F0-A176-10066FF42CBCQ37118241-B180A617-B31A-4FFF-8BC6-AB916B5F8D85Q37169655-4F2BB0DC-2A57-4035-8FB0-0259F7219387Q37506514-7EAA9579-4C53-40AA-8EA9-286DB1E3C3F5Q37882584-E4FEACF6-C625-4AAB-9031-4D2DD9D64BBDQ37916221-92971880-D1E3-4A28-B8FA-D54DDB16CFA8Q38102579-01FB122C-821C-4933-A454-1FBB00AA64DAQ38163877-7E147229-4CCA-421D-8E99-A88F16FAFD0EQ38202178-4D4BFFB7-A31C-4DD7-B1C5-60E96B188EA3Q38248687-F99EA29F-35FE-43DD-B452-60CD6F1BBFFEQ38633556-1E5C2989-884F-42E5-B58D-8C44D628E447Q38663617-D8C86964-A765-48B8-BAA6-CCC45801A70CQ39004244-784DB4EA-6D4D-4F2E-9800-401B24008775Q39190617-7B341B6C-BAF7-4250-834E-D3AEB11E65F1Q40998916-4762FEEB-20C2-46D4-8075-A14DA29FFA8DQ45305225-D6E362CF-2810-407C-B442-1B0007ACE007Q45305909-9FBCD022-5FF7-49E9-BA95-ADA31147F7D4Q55081064-8B16ED17-B171-4E91-92D3-0E14AD7BCE27Q57471756-95ACF4F5-BFA1-4A10-A32A-AD9EB0DA2081Q58574520-754652C1-012B-4E0F-9AB2-0E4EAD7BCEBE
P2860
A futility study of minocycline in Huntington's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A futility study of minocycline in Huntington's disease.
@ast
A futility study of minocycline in Huntington's disease.
@en
A futility study of minocycline in Huntington's disease.
@nl
type
label
A futility study of minocycline in Huntington's disease.
@ast
A futility study of minocycline in Huntington's disease.
@en
A futility study of minocycline in Huntington's disease.
@nl
prefLabel
A futility study of minocycline in Huntington's disease.
@ast
A futility study of minocycline in Huntington's disease.
@en
A futility study of minocycline in Huntington's disease.
@nl
P356
P1433
P1476
A futility study of minocycline in Huntington's disease.
@en
P2093
Huntington Study Group DOMINO Investigators
P2860
P304
P356
10.1002/MDS.23236
P407
P577
2010-10-01T00:00:00Z